Home 5 Articles 5 FDA Watch: VALID and VITAL Bills for LDTs Regulation Are Back in Play

FDA Watch: VALID and VITAL Bills for LDTs Regulation Are Back in Play

by | Aug 17, 2021

Reform of FDA Laboratory Developed Tests (LDTs) regulation is back on the agenda and this time it may result in actual legislation. Fired by the agency’s ineffectiveness in bringing new SARS-CoV-2 tests to market rapidly during the early days of the public health emergency, Congress exhumed the VALID and VITAL Acts proposing different approaches to […]

Reform of FDA Laboratory Developed Tests (LDTs) regulation is back on the agenda and this time it may result in actual legislation. Fired by the agency’s ineffectiveness in bringing new SARS-CoV-2 tests to market rapidly during the early days of the public health emergency, Congress exhumed the VALID and VITAL Acts proposing different approaches to […]

This content is Exclusive to Lab Industry Report Subscribers

Subscribe or Log in for Exclusive Access.